Form 4 Tracker
Atara Biotherapeutics, Inc.
ATRA

16 insider filings · Latest: Sep 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 16, 2025May 16 11:27 PMGrant-Huerta Yanina
Proposed Sale
2,350$7.61$17.9K—

View →

Mar 3, 2025Mar 3 11:30 PMNguyen AnhCo
Proposed Sale
3,929$6.91$27.1K—

View →

Mar 3, 2025Mar 3 11:29 PMHyllengren Eric J
Proposed Sale
1,426$6.91$9.9K—

View →

Mar 3, 2025Mar 3 11:27 PMHenrich Jill
Proposed Sale
1,245$6.91$8.6K—

View →

Nov 18, 2024Nov 18 10:58 PMNguyen AnhCo
Proposed Sale
1,857$12.00$22.3K—

View →

Nov 18, 2024Nov 18 10:56 PMMurugan Amar
Proposed Sale
1,342$12.00$16.1K—

View →

Nov 18, 2024Nov 18 10:55 PMHyllengren Eric J
Proposed Sale
1,517$12.00$18.2K—

View →

Nov 18, 2024Nov 18 10:54 PMHenrich Jill
Proposed Sale
1,112$12.00$13.3K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 22, 2026Jul 25 1:00 AMRedmile Group, LLCDirector
Option Exercise
195,211—0(I)

View →

Mar 17, 2026Mar 19 8:30 PMPanacea Innovation Ltd10% Owner
Option Exercise
259,163$0.00010(I)

View →